CTC-derived AR-V7 detection as a prognostic and predictive biomarker in advanced prostate cancer”

24th August

Read Emmanuel Antonarakis excellent review CTC-derived AR-V7 detection as a prognostic and predictive biomarker in advanced prostate cancer in Expert Review of Molecular Diagnostics.

AR-V7 and also other cancer biomarkers are easily tested for using the AdnaTest Prostate and TATAA GrandPerformance cancer assays.